{
 "companyname": "DISCOVERY LABORATORIES INC /DE/",
 "symbol": "DSCO",
 "description": "Biological Products, Except Diagnostic Substances",
 "quarters": [
  {
   "cik": "0000946486",
   "companyname": "DISCOVERY LABORATORIES INC /DE/",
   "entityid": 5331,
   "primaryexchange": "Nasdaq Capital Market",
   "primarysymbol": "DSCO",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/5/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001140361-15-039840",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 558000,
   "changeincurrentliabilities": 362000,
   "changeininventories": 0,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -5000,
   "cashfromfinancingactivities": 27744000,
   "cashfrominvestingactivities": -5000,
   "cashfromoperatingactivities": -7522000,
   "cfdepreciationamortization": 203000,
   "changeinaccountsreceivable": 0,
   "investmentchangesnet": null,
   "netchangeincash": 20217000,
   "totaladjustments": 14034000,
   "ebit": -8443000,
   "costofrevenue": 0,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 66000,
   "incomebeforetaxes": -21556000,
   "interestexpense": -1495000,
   "netincome": -21556000,
   "netincomeapplicabletocommon": -21556000,
   "researchdevelopmentexpense": 6452000,
   "totalrevenue": 66000,
   "sellinggeneraladministrativeexpenses": 2057000,
   "commonstock": 112000,
   "deferredcharges": null,
   "cashandcashequivalents": 46308000,
   "cashcashequivalentsandshortterminvestments": 46308000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": 0,
   "minorityinterest": null,
   "otherassets": 2594000,
   "othercurrentassets": null,
   "othercurrentliabilities": 497000,
   "otherequity": null,
   "otherliabilities": 56000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 1186000,
   "retainedearnings": -569069000,
   "totalassets": 52732000,
   "totalcurrentassets": 48727000,
   "totalcurrentliabilities": 9786000,
   "totalliabilities": 34842000,
   "totallongtermdebt": 25000000,
   "totalreceivablesnet": null,
   "totalshorttermdebt": 0,
   "totalstockholdersequity": 17890000,
   "treasurystock": -3054000
  },
  {
   "cik": "0000946486",
   "companyname": "DISCOVERY LABORATORIES INC /DE/",
   "entityid": 5331,
   "primaryexchange": "Nasdaq Capital Market",
   "primarysymbol": "DSCO",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/10/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001140361-15-030749",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 5000,
   "changeincurrentliabilities": 1001000,
   "changeininventories": 0,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -55000,
   "cashfromfinancingactivities": -21000,
   "cashfrominvestingactivities": 205000,
   "cashfromoperatingactivities": -9676000,
   "cfdepreciationamortization": 730000,
   "changeinaccountsreceivable": 0,
   "investmentchangesnet": null,
   "netchangeincash": -9492000,
   "totaladjustments": 1650000,
   "ebit": -10437000,
   "costofrevenue": 0,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 75000,
   "incomebeforetaxes": -11326000,
   "interestexpense": -1359000,
   "netincome": -11326000,
   "netincomeapplicabletocommon": -11326000,
   "researchdevelopmentexpense": 7129000,
   "totalrevenue": 75000,
   "sellinggeneraladministrativeexpenses": 3383000,
   "commonstock": 86000,
   "deferredcharges": null,
   "cashandcashequivalents": 26091000,
   "cashcashequivalentsandshortterminvestments": 26091000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": 0,
   "minorityinterest": null,
   "otherassets": 68000,
   "othercurrentassets": null,
   "othercurrentliabilities": 820000,
   "otherequity": null,
   "otherliabilities": 59000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 1245000,
   "retainedearnings": -547513000,
   "totalassets": 28200000,
   "totalcurrentassets": 26662000,
   "totalcurrentliabilities": 9768000,
   "totalliabilities": 31278000,
   "totallongtermdebt": 21451000,
   "totalreceivablesnet": null,
   "totalshorttermdebt": 21000,
   "totalstockholdersequity": -3078000,
   "treasurystock": -3054000
  },
  {
   "cik": "0000946486",
   "companyname": "DISCOVERY LABORATORIES INC /DE/",
   "entityid": 5331,
   "primaryexchange": "Nasdaq Capital Market",
   "primarysymbol": "DSCO",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/11/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001140361-15-018817",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 446000,
   "changeincurrentliabilities": 1417000,
   "changeininventories": 201000,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -448000,
   "cashfromfinancingactivities": -20000,
   "cashfrominvestingactivities": -448000,
   "cashfromoperatingactivities": -8660000,
   "cfdepreciationamortization": 980000,
   "changeinaccountsreceivable": 0,
   "investmentchangesnet": null,
   "netchangeincash": -9128000,
   "totaladjustments": 3519000,
   "ebit": -11173000,
   "costofrevenue": 929000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": -738000,
   "incomebeforetaxes": -12179000,
   "interestexpense": -1208000,
   "netincome": -12179000,
   "netincomeapplicabletocommon": -12179000,
   "researchdevelopmentexpense": 7082000,
   "totalrevenue": 191000,
   "sellinggeneraladministrativeexpenses": 3353000,
   "commonstock": 86000,
   "deferredcharges": null,
   "cashandcashequivalents": 35583000,
   "cashcashequivalentsandshortterminvestments": 35583000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": 0,
   "minorityinterest": null,
   "otherassets": 73000,
   "othercurrentassets": null,
   "othercurrentliabilities": 1289000,
   "otherequity": null,
   "otherliabilities": 196000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 1665000,
   "retainedearnings": -536187000,
   "totalassets": 38122000,
   "totalcurrentassets": 36159000,
   "totalcurrentliabilities": 9257000,
   "totalliabilities": 30310000,
   "totallongtermdebt": 20857000,
   "totalreceivablesnet": null,
   "totalshorttermdebt": 42000,
   "totalstockholdersequity": 7812000,
   "treasurystock": -3054000
  }
 ]
}